Figure 2

![Figure 2: Clinical evidence summary for Souvenaid efficacy in mild cognitive impairment, drawn from the expert consensus review. The data synthesize outcomes from key clinical trials evaluating cognitive and functional endpoints.]()

> Source: Jeffrey Cummings et al. "Souvenaid in the management of mild cognitive impairment: an expert consensus op." *Alzheimer's research & therapy*, 2019. PMID: [31421681](https://pubmed.ncbi.nlm.nih.gov/31421681/)

<figure>
  <img src="" alt="Clinical evidence summary for Souvenaid efficacy in mild cognitive impairment, drawn from the expert consensus review. The data synthesize outcomes from key clinical trials evaluating cognitive and functional endpoints." />
  <figcaption>Figure 2. Clinical evidence summary for Souvenaid efficacy in mild cognitive impairment, drawn from the expert consensus review. The data synthesize outcomes from key clinical trials evaluating cognitive and functional endpoints.<br>  Source: Jeffrey Cummings et al. "Souvenaid in the management of mild cognitive impairment: an expert consensus op." <em>Alzheimer's research & therapy</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31421681/">31421681</a></figcaption>
</figure>